Kim Schmid focuses her litigation practice on defending companies in drug and medical device cases in courts across the country. In addition to her defense litigation practice where she is currently serving as National Coordinating Counsel in medical device mass tort litigation, she advises her clients on FDA regulatory compliance and reporting requirements. Kim has defended individual lawsuits, class actions, cases involved in mass tort and multi-district litigation (MDL).
In courts, Kim has extensive experience defending medical device products including latex gloves, breast implants, hip stem implants, infusion pumps, orthopedic devices, implantable cardiac care devices, suction devices, surgical instruments, device monitors, blood warming units and more. She has defended IDE products utilized in clinical trials as well as Class I, II and III FDA cleared devices. Kim has defended pharmaceutical cases involving generics, branded, OTC and Rx medications. She has written several articles and presented at national seminars on issues specific to drug and device litigation such as preemption, successful Daubert challenges and other evidence based motions.
Kim is a member of the firm's Executive Committee where she has leadership responsibility for strategic and overall firm management. She is also an active member of the DRI and ABA’s Drug and Medical Device Subcommittees and LifeScience Alley. In 2010, she was named Attorney of the Year at Medmarc's annual defense counsel meeting in Charleston, South Carolina. Medmarc, the nation's leading insurance provider to manufacturers and distributors of medical technology and life sciences products, selected Kim from more than 300 attorneys who represent the industry. Additionally, Kim was recently recognized by The Legal 500 for her outstanding work in the Medical Device category.